Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia.

The influence of infecting serotype group on outcome in bacteraemic pneumococcal pneumonia remains unclear. We performed a prospective, 10-yr observational study in an 800-bed teaching hospital. 299 adults diagnosed with pneumonia whose blood cultures showed growth of Streptococcus pneumoniae were included in the study.

Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia.

Background: A cohort of patients with bacteremic Streptococcus pneumoniae pneumonia was reviewed to assess why mortality is higher in health-care-associated pneumonia (HCAP) than in community-acquired pneumonia (CAP).

Methods: A prospective cohort of all adult patients with bacteremic pneumococcal pneumonia attended at the ED was used.

Results: One hundred eighty-four cases were classified as CAP and 44 (19%) as HCAP.

Pleuropulmonary Toxicity of Another Anti-Parkinson's Drug: Cabergoline.

Many drugs may cause toxic injury to the lungs and the pleura. Cabergoline is an ergoline derivative which has been used in Spain for seven years to control symptoms of Parkinson's disease. We report a patient with dyspnea, bilateral pleural effusion and distal swelling.

[Causes of death and risk factors for mortality in patients with severe chronic obstructive pulmonary disease].

Objective: The objective of this study was to assess the causes of death and risk factors for mortality in a cohort of patients with severe chronic obstructive pulmonary disease (COPD).

Patients And Methods: We studied 203 patients with severe COPD (forced expiratory volume in 1 second [FEV(1)] <50%), who were attended in our respiratory department day hospital (2001-2006). Clinical variables were recorded on inclusion, and clinical course and causes of death were retrospectively reviewed.